ProfileGDS5678 / 1419632_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 45% 45% 45% 45% 45% 45% 45% 45% 44% 45% 45% 45% 45% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.092245
GSM967853U87-EV human glioblastoma xenograft - Control 23.0543245
GSM967854U87-EV human glioblastoma xenograft - Control 33.0426845
GSM967855U87-EV human glioblastoma xenograft - Control 42.9988445
GSM967856U87-EV human glioblastoma xenograft - Control 52.9958845
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.153745
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1249745
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0302945
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0134644
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.024445
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.03845
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0176145
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0469345
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0418345